North Texas Institute for Clinical Trials

Fort Worth, Texas TX 76132

0 studies enrolling now · 10 studies all time

What they study most

Allergic Rhinitis, Asthma, Atopic Dermatitis, Histamine Responsive Allergy Patients, Perennial Allergic Rhinitis, Persistent Allergic Asthma, Type I Hypersensitivity

Studies at this site

• A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis — Stopped early
• A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma — Completed
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma — Completed
• Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma — Completed
• Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma — Completed
• Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation. — Completed
• The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing — Completed
• Efficacy and Safety/Tolerability of Ragweed MATA MPL — Completed